InvestorsHub Logo
Followers 71
Posts 2591
Boards Moderated 0
Alias Born 12/10/2009

Re: willpellel post# 158091

Tuesday, 02/25/2020 9:22:02 AM

Tuesday, February 25, 2020 9:22:02 AM

Post# of 223538
This just in...In an about face pivot that would make your head spin, GNCP's is in a position to commence to announce shortly the intent to commence the early stages of considering entering the bio=pharma space. In a conversation with reporters from the Street Insider, management was asked what was the motivation to move away from the mining, minerals and CBD space, to bio-pharma, Ron Lowenthal replied..."We do 180 degree pivots standing on our heads so this aint no thang my gentile bruh! GNCP will be exploring the possibility of extending its focus to included bio-pharma in order to deliver a vaccine that will be effective in the fight against the COVID19 responsible for over 2,000 deaths and over 70,000 cases reported to date in over 15 countries. The virus, which has the potential to become a pandemic started in Wuhan China could spread globally according to some exponential and geometric models. A phase I vaccine is still at least 3 months out and a deliverable efficacious vaccine anywhere from six months to a year out. PDIV will shift its considerable economic weight to establish labs and testing facilities to expedite a deliverable sooner than current methods already in place.

Scientist hired by GNCP were able to quickly identify the genetic sequence of the new coronavirus, allowing GNCP's newly assembled scientific research teams to get to work right away.

With the genetic code in hand, GNCP's scientists can now start vaccine development work without needing a sample of the virus.

During the deadly 2003 Severe Acute Respiratory Syndrome (SARS) outbreak, it took US scientists 20 months to go from genetic sequence to the first phase of human trials. By that time, the outbreak was under control.

This time, research groups worldwide are already executing plans to test vaccines with the help of GNCP's leadership, treatments and other countermeasures to stop the newly identified virus from spreading globally.

Hey Ron!!!! You're just not trying very hard. This press release practically writes itself!